Dealing with respiratory failure has been a huge challenge in the Covid-19 pandemic. NeuroRx and Relief Therapeutics have teamed up to study RLF-100 on these critical Covid-19 patients. The pair is now planning to study the drug in less severe patients to see if it can also prevent disease progression. How could RLF-100’s mechanism of […]

In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Seth Lederman, co-founder, CEO and chairman of Tonix Pharmaceuticals. Seth and Mike explored the two programs Tonix are currently developing in pain and psychiatry, areas where many larger companies have turned their back […]

Dr. Paul Wotton, CEO of Obsidian Therapeutics, discusses Obsidian’s platform, cytoDRiVE™, that regulates protein levels in cell and gene therapies, creating an “operating system” for living drugs. This means that now, and for the first time, physicians will be able to control genetically-engineered cells’ biologic activity to increase efficacy and reduce toxicity, using easily accessed generics […]